Critical Drug Interactions With Agents Used for Prophylaxis and Treatment of Mycobacterium avium Complex Infections
- 26 May 1997
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 102 (5) , 32-36
- https://doi.org/10.1016/s0002-9343(97)00042-9
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Drug Interactions in Patients Infected with Human Immunodeficiency VirusClinical Infectious Diseases, 1996
- Pharmacokinetics of lamivudine administered alone and with trimethoprim-sulfamethoxazole*Clinical Pharmacology & Therapeutics, 1996
- Reduced Serum Levels Of Clarithromycin In Patients Treated With Multi-Drug Regimens Including Rifampin Or Rifabutin For Mycobacterium Avium-M. Intracellulare InfectionThe Journal of Infectious Diseases, 1995
- Fluconazole and Enhanced Effect of Rifabutin ProphylaxisNew England Journal of Medicine, 1994
- Rifabutin Prophylaxis and UveitisNew England Journal of Medicine, 1994
- Comparison of the Effect of the Macrolide Antibiotics Erythromycin, Clarithromycin and Azithromycin on Terfenadine Steady-State Pharmacokinetics and Electrocardiographic ParametersClinical Drug Investigation, 1994
- Uveitis and Pseudojaundice During a Regimen of Clarithromycin, Rifabutin, and EthambutolNew England Journal of Medicine, 1994
- Speculations on the Substrate Structure-Activity Relationship (SSAR) of cytochrome P450 enzymesBiochemical Pharmacology, 1992
- P450 EnzymesClinical Pharmacokinetics, 1992
- Increased Gastric pH and the Bioavailability of Fluconazole and KetoconazoleAnnals of Internal Medicine, 1991